Hubei Yihua Chemical 湖北宜化
38 significant filings since 30 May 2026: 19 on share issue, 5 on equity incentive and 5 on guarantee or financial assistance, and 3 other kinds. The latest, on 24 Sep 2026: 关于2024年限制性股票激励计划部分限制性股票回购注销完成的公告.
自 30 May 2026 起有 38 份重大公告：share issue 19 份、equity incentive 5 份、guarantee or financial assistance 5 份，另有 3 类。最新一份（24 Sep 2026）：关于2024年限制性股票激励计划部分限制性股票回购注销完成的公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
No broker has changed its rating on this company in the reports held.
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 西南证券 | 钱伟伦,甄理 | Buy 买入 | 20 Aug 2026 | 1 | 15.39 |
| 国信证券 | 杨林,张歆钰 | Outperform 增持 | 13 Aug 2026 | 2 | — |
| 华安证券 | 王强峰,刘天其 | Buy 买入 | 6 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 1 of 4 reports. 每行为该券商近十二个月的最新研报；4 份中 1 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。